Synthesis of novel tricalcium phosphate-bioactive glass composite and functionalization with rhBMP-2

Journal of Materials Science: Materials in Medicine

Volumn 22, Issue 4, 2011, Pages 763-771

  Schickle, Karolina ^a   Zurlinden, Kristin ^b   Bergmann, Christian ^a   Lindner, Markus ^a   Kirsten, Armin ^a   Laub, Markus ^b   Telle, Rainer ^c   Jennissen, Herbert ^b   Fischer, Horst ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3-AMINOPROPYLTRIETHOXYSILANE; AFTER-TREATMENT; BONE REMODELING; BONE SUBSTITUTES; CARBONYLDIIMIDAZOLE; COVALENTLY BOUND; CRYSTALLINE PHASIS; FUNCTIONALIZATIONS; GLASS COMPOSITES; RHBMP-2; RHENANITE; SEM ANALYSIS; TRI-CALCIUM PHOSPHATES;

BONE; CALCIUM PHOSPHATE; SILICATE MINERALS; SILICON COMPOUNDS; SINTERING; SULFURIC ACID; SURFACES;

BIOACTIVE GLASS;

1,2' CARBONYLDIIMIDAZOLE; 3 AMINOPROPYLTRIETHOXYSILANE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CERAMIC; CALCIUM SILICATE; CHROME SULFURIC ACID; GLASS; IMIDAZOLE DERIVATIVE; INORGANIC SALT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RHENANITE; SULFURIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIOACTIVE GLASS COMPOSITE; BIOLOGICAL ACTIVITY; CHEMICAL COMPOSITION; COMPOSITE MATERIAL; CONTROLLED STUDY; COVALENT BOND; HEATING; MORPHOLOGY; POWDER; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SCANNING ELECTRON MICROSCOPY; SINTERING; SURFACE PROPERTY; SYNTHESIS; X RAY DIFFRACTION; X RAY FLUORESCENCE;

3T3 CELLS; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REMODELING; BONE SUBSTITUTES; CALCIUM PHOSPHATES; GLASS; HUMANS; IMIDAZOLES; MATERIALS TESTING; MICE; MICROSCOPY, ELECTRON, SCANNING; RECOMBINANT PROTEINS; SILANES; SULFURIC ACIDS; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 80051673330     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4252-4     Document Type: Article

References (31)

1. 3 system. J Mater Sci Mater Med. 1990;1:219-327.
2. Ohsawa K, Neo M, Okamoto T, Tamura J, Nakamura T. In Vivo absorption of porous apatite-and wollastonite-containing glassceramic. J Mater Sci Mater Med. 2004;15:859-64. (Pubitemid 39070213)
3. Teramoto H, Kawai A, Sugihara S, Yoshida A, Inoue H. Resorption of apatite-wollastonite containing glass-ceramic and beta-tricalcium phosphate in vivo. Acta med Okayama. 2005;59:201-7. (Pubitemid 43143774)
4. Driessens FCM, Ramselaar MMA, Schaeken HG, Stols ALH, Van Mullem PJ. Chemical reactions of calcium phosphate implants after implantation in vivo. J Mater Sci Mater Med. 1992;3:413-7.
5. Ramselaar MMA, Driessens FCM, Kalk W. Biodegradation of four calcium phosphate ceramics; in vivo rates and tissue interactions. J Mater Sci Mater Med. 1991;2:63-70.
6. Yu X, Cai S, Zhang Z, Gouhau X. Bioactive pyrophosphate glass/beta-tricalcium phosphate composite with high mechanical properties. Mater Sci Eng. 2008; C28:1138-43.
7. Gerber T, Traykova T, Henkel K-O, Bienengraeber V, Witt M, Koewitz J. Silica/calcium phosphate sol-gel derived bone grafting material and bone remodelling. An eight months in vivo study. Key Eng Mater. 2003;240-242:411-4.
8. Knowles JC, Talal S, Santos JD. Sintering effect in a glass reinforced hydroxyapatite. Biomaterials. 1996;17:1437-42. (Pubitemid 26237552)
9. Knowles JC, Bonfield W. Development of a glass reinforced mechanical properties. The effect of glass composition on mechanical properties and its relationship to phase changes. J Biomed Mater Res. 1993;27:1591-8. (Pubitemid 23341488)
10. Scheuffler C, Sebald W, Hulsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol. 1999;287:103-15. (Pubitemid 29134800)
11. Laub M, Seul T, Schmachtenberg E, Jennissen HP. Molecular modelling of bone morphogenetic protein-2 (BMP-2) by 3D-rapid prototyping. Materialwiss Werkstofftech. 2001;32:926-30. (Pubitemid 33382260)
12. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblasticcells, MC3T3-E1. Biochem Biophys Res Commun. 2001;174:96-101.
13. Laub M, Chatzinikolaidou M, Jennissen HP. Aspects of BMP-2 binding to receptors and collagen: influence of cell senescence on receptor binding and absence of high-affinity stoichiometric binding to collagen. Materialwiss Werkstofftech. 2007;38:1019-26.
14. Chatzinikolaidou M, Laub M, Rumpf HM, Jennissen HP. Biocoating of electropolished and ultra-hydrophilic titanium and cobalt chromium molybdenum alloy surfaces with proteins. Materialwiss Werkstofftech. 2002;33:720-7. (Pubitemid 36201858)
15. Chatzinikolaidou M, Zumbrink T, Jennissen HP. Stability of surface-enhanced ultrahydrophilic metals as a basis for bioactive rhBMP-2 surfaces. Materialwiss Werkstofftech. 2003;34:1106-12. (Pubitemid 38127440)
16. Zurlinden K, Laub M, Jennissen HP. Chemical functionalization of a hydroxyapatite based bone replacement material for the immobilization of proteins. Materialwiss Werkstofftech. 2005;36:820-7. (Pubitemid 43058085)
17. Jennissen HP, Zumbrink T, Chatzinikolaidou M, Steppuhn J. Biocoating of implants with mediator molecules: surface enhancement of metals by treatment with chromosulfuric acid. Materialwiss Werkstofftech. 1999;30:838-45. (Pubitemid 129319580)
18. Rumpf HM, Dopp E, Rettenmeier AW, Chatzinikolaidou M, Jennissen HP. Absence of genotoxic effects after exposure of mammalian cells to the recombinant human bon morphogenetic protein 2 (BMP-2) prepared from E. coli. Materialwiss Werkstofftech. 2003;34:1101-5. (Pubitemid 38127439)
19. Wiemann M, Rumpf HM, Bingmann D, Jennissen HP. The binding of rhBMP-2 to the receptors of viable MC3T3-E1 cells and the question of cooperativity. Materialwiss Werkstofftech. 2001;32:931-6. (Pubitemid 33382261)
20. Gong W, Abdelouas A, Lutze W. Porous bioactive glass and glass-ceramics made by reaction sintering under pressure. J Biomed Mater Res. 2001;54:320-7. (Pubitemid 32016695)
21. Kangasniemi I, de Groot K, Wolke J, Andersson O, Luklinska Z, Becht JGM, Lakkisto M, Yli-Urpo A. The stability of hydroxyapatite in an optimized bioactive glass matrix at sintering temperatures. J Mater Sci Mater Med. 1991;2:133-7.
22. Hesaraki S, Safari M, Shorgozar MA. Composite bone substitute materials based on β-tricalcium phosphate and magnesium-containing sol-gel derived bioactive glass. J Mater Sci Mater Med. 2009;20:2011-7.
23. 4) and hydroxyapatite biphasic biomaterial for skeletal repair. J Biomed Mater Res Part B. 2007;80B:304-16.
24. Höland W, Rheinberger V, Apel E, van't Hoen C, Höland M, Dommann A, Obrecht M, Mauth C, Graf-Hausner U. Clinical applications of glass-ceramic in dentistry. J Mater Sci Mater Med. 2006;17:1037-42.
25. Xu S, Lin K, Wang Z, Chang J, Wang L, Lu J, Ning C. Reconstruction of calvaria defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials. 2008;29:2588-96.
26. 2 composite materials for hard tissue repair: In vitro studies. J Biomed Mater Res Part A. 2008;85A:72-82. (Pubitemid 351355356)
27. 2/glass composite Ecopore with heparinised collagen and the osteoinductive factor BMP-2. Acta Biomater. 2008;4:997-1004.
28. Uludag H, Friess W, Williams D, Porter T, Timony G, Augusta DD, Blake C, Palmer R, Biron B, Wozney J. RhBMP-2-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP-2 pharmokinetics. Ann NY Acad Sci. 1999;875:369-78. (Pubitemid 29349087)
29. Crowley SC, Chan KC, Walters RR. Optimization of protein immobilization on 1, 10-carbonyldiimidazole-activated diol-bonded silica. J Chromatogr. 1986;359:359-68.
30. Phillips A. Overview of the fracture healing cascade. Injury. 2005;36S:S5-7.
31. Lichtinger TK, Müller RT, Schurmann N, Oldenburg M, Wiemann M, Chatzinikolaidou M, Rumpf HM, Jennissen HP. Osseointegration of titanium implants by addition of recombinant bone morphogenetic protein 2 (rhBMP-2). Materialwiss Werkstofftech. 2001;32:937-41. (Pubitemid 33382262)